| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ||||||||||||||||||||||||||
2 | Date | Title | Contributors | |||||||||||||||||||||||
3 | Viral Pathogens Research Theme | VPEI | ||||||||||||||||||||||||
4 | 2 Feb 2023 | Thirty years of change in HIV incidence among adults in the Kyamulibwa General Population Cohort in rural southwest Uganda, 1989-2021. Int J Infect Dis. 2023 Apr;129:125-134. doi: 10.1016/j.ijid.2023.01.029. Epub 2023 Feb 2. PMID: 36736994. | Kasamba I, Mugisha J, Abaasa A, Makanga R, Ruzagira E, Kaleebu P, Seeley J, Newton R; Kyamulibwa General Population Cohort team of Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit. | VPEI | ||||||||||||||||||||||
5 | 18 Apr 2023 | Equity and behavioral digital health interventions: Strategies to improve benefit and reach | Sarah J Miller 1, Jamilia R Sly 1, Kassandra I Alcaraz 2, Kimlin Ashing 3, Shannon M Christy 4 5, Brian Gonzalez 4 5, Qian Lu 6, Robert L Newton 7, Michelle Redmond 8, Megan Shen 9, Kamilah Thomas-Purcell 10, Jean Yi 9, Tiffany Veinot 11, Cathy D Meade 4 5 | TB and VPEI | ||||||||||||||||||||||
6 | 19 Apr 2023 | Prevalence and Factors Associated with Illicit Drug and High-Risk Alcohol Use among Adolescents Living in Urban Slums of Kampala, Uganda | Hellen Kalungi 1, Onesmus Kamacooko 1, Jane Frances Lunkuse 1, Joy Namutebi 1, Rose Naluwooza 1, Matt A Price 2, Eugene Ruzagira 1, Yunia Mayanja 1 | V4V and VPEI | ||||||||||||||||||||||
7 | 7 May 2023 | Effect of the "universal test and treat" policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda | Levicatus Mugenyi 1, Christian H Hansen 1 2, Philippe Mayaud 1 2, Janet Seeley 1 2, Robert Newton 1, Mastula Nanfuka 3, Andrew Abaasa 1, Kenneth Mugisha 3, Michael Etukoit 3, Pontiano Kaleebu 1 2, Eugene Ruzagira 1 2 | |||||||||||||||||||||||
8 | 9 May 2023 | Vaccination against SARS-CoV-2 in a rural Ugandan population | Joseph Mugisha 1, Bernard Mpairwe 1, Beatrice Kimono 1, Pontiano Kaleebu 1, Robert Newton 1 | VPEI | ||||||||||||||||||||||
9 | 26 May 2023 | Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens | Hellen Nantambi 1 2 3, Jackson Sembera 1 2, Violet Ankunda 2, Ivan Ssali 1, Arthur Watelo Kalyebi 2 3, Gerald Kevin Oluka 1 2, Laban Kato 1, Bahemuka Ubaldo 1, Freddie Kibengo 1, Joseph Ssebwana Katende 1 2, Ben Gombe 1, Claire Baine 2, Geoffrey Odoch 1, Susan Mugaba 1, Obondo James Sande 3; COVID-19 Immunoprofiling Team; Pontiano Kaleebu 1 2, Jennifer Serwanga 1 2 | VPEI | ||||||||||||||||||||||
10 | 10 Jun 2023 | HIV specific Th1 responses are altered in Ugandans with HIV and Schistosoma mansoni coinfection | Andrew Ekii Obuku 1, Jacqueline Kyosiimire Lugemwa 2, Andrew Abaasa 2, Moses Joloba 3, Song Ding 4, Justin Pollara 5, Guido Ferrari 5, Alexandre Harari 6, Giuseppe Pantaleo 7, Pontiano Kaleebu 2 8 | VPEI | ||||||||||||||||||||||
11 | 20 Jul 2023 | Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses | Roshell Muir 1, Talibah Metcalf 1, Slim Fourati 2, Yannic Bartsch 3, Jacqueline Kyosiimire-Lugemwa 4, Glenda Canderan 5, Galit Alter 3, Enoch Muyanja 2 6, Brenda Okech 6, Teddy Namatovu 6, Irene Namara 6, Annemarie Namuniina 6, Ali Ssetaala 6, Juliet Mpendo 6, Annet Nanvubya 6, Paul Kato Kitandwe 4, Bernard S Bagaya 7, Noah Kiwanuka 8, Jacent Nassuna 8, Victoria Menya Biribawa 6, Alison M Elliott 4 9, Claudia J de Dood 10, William Senyonga 4, Priscilla Balungi 4, Pontiano Kaleebu 4, Yunia Mayanja 4, Matthew Odongo 4, Jennifer Connors 1, Pat Fast 11 12, Matt A Price 11 13, Paul L A M Corstjens 10, Govert J van Dam 14, Anatoli Kamali 6 11 15, Rafick Pierre Sekaly 2, Elias K Haddad 1 | VPEI | ||||||||||||||||||||||
12 | 4 Jan 2024 | Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda | Geofrey Kimbugwe 1, Renaud Vatrinet 2, Juliet A Mwanga 3, Ronald Kakuru 3, Doreen Mpeirwe 3, Suzan Logoose 3, Kimton Opio 3, Mateus Kambale 3, Janet Seeley 4, Rebecca F Grais 2, Caroline Marquer 2, Pontiano Kaleebu 5, Agnes Ssali 4 | VPEI | ||||||||||||||||||||||
13 | VPDD | |||||||||||||||||||||||||
14 | Oncogenic | |||||||||||||||||||||||||
15 | 8 Jun 2023 | Differential regulation of BIRC2 and BIRC3 expression by inflammatory cytokines and glucocorticoids in pulmonary epithelial cells. PLoS One. 2023 Jun 8;18(6):e0286783. doi: 10.1371/journal.pone.0286783. PMID: 37289679; PMCID: PMC10249814. | Thorne A, Bansal A, Necker-Brown A, Mostafa MM, Gao A, Georgescu A, Kooi C, Leigh R, Newton R. | |||||||||||||||||||||||
16 | 13 Apr 2023 | Prevalence and Factors Associated with Illicit Drug and High-Risk Alcohol Use among Adolescents Living in Urban Slums of Kampala, Uganda | Hellen Kalungi 1, Onesmus Kamacooko 1, Jane Frances Lunkuse 1, Joy Namutebi 1, Rose Naluwooza 1, Matt A Price 2 3, Eugene Ruzagira 1 4, Yunia Mayanja 1 4 | |||||||||||||||||||||||
17 | 15 May 2023 | Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout. Int J Cancer. 2023 May 15;152(10):2081-2089. doi: 10.1002/ijc.34454. Epub 2023 Feb 15. PMID: 36727 | Motlhale M, Muchengeti M, Bradshaw D, Chen WC, Singini MG, de Villiers CB, Lewis CM, Bender N, Mathew CG, Newton R, Waterboer T, Singh E, Sitas F. | |||||||||||||||||||||||
18 | 9 Jun 2023 | Effect of the "universal test and treat" policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda. Front Public Health. 2023 Jun 9;11:1187274. doi: 10.3389/fpubh.2023.1187274. PMID: 37361157; PMCID: | Mugenyi L, Hansen CH, Mayaud P, Seeley J, Newton R, Nanfuka M, Abaasa A, Mugisha K, Etukoit M, Kaleebu P, Ruzagira E. | |||||||||||||||||||||||
19 | 12 Jun 2023 | Sickle cell allele HBB-rs334(T) is associated with decreased risk of childhood Burkitt lymphoma in East Africa | Hyokyoung G Hong 1, Mateus H Gouveia 2, Martin D Ogwang 3 4, Patrick Kerchan 4 5, Steven J Reynolds 6, Constance N Tenge 7, Pamela A Were 8, Robert T Kuremu 7, Walter N Wekesa 7, Nestory Masalu 9, Esther Kawira 10, Tobias Kinyera 3 4, Xunde Wang 11, Jiefu Zhou 12, Thiago Peixoto Leal 13, Isaac Otim 3 4, Ismail D Legason 4 5, Hadijah Nabalende 3 4, Herry Dhudha 9, Mediatrix Mumia 8, Francine S Baker 1, Temiloluwa Okusolubo 11, Leona W Ayers 14, Kishor Bhatia 1, James J Goedert 1, Joshua Woo 1, Michelle Manning 15, Nathan Cole 15, Wen Luo 15, Belynda Hicks 15, George Chagaluka 16, W Thomas Johnston 17, Nora Mutalima 17 18, Eric Borgstein 16, George N Liomba 16, Steve Kamiza 16, Nyengo Mkandawire 16, Collins Mitambo 19, Elizabeth M Molyneux 16, Robert Newton 17, Amy Hutchinson 15, Meredith Yeager 15, Adebowale A Adeyemo 2, Swee Lay Thein 11, Charles N Rotimi 2, Stephen J Chanock 1, Ludmila Prokunina-Olsson 1, Sam M Mbulaiteye 1 | |||||||||||||||||||||||
20 | 14 Jun 2023 | Comparison of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3-89 years from Uganda. Infect Agent Cancer. 2023 Jun 14;18(1):38. doi: 10.1186/ | Nalwoga A, Marshall V, Miley W, Labo N, Whitby D, Newton R, Rochford R. | |||||||||||||||||||||||
21 | 27 Jun 2023 | IFNL4 Genotypes and Risk of Childhood Burkitt Lymphoma in East Africa. J Interferon Cytokine Res. 2023 Sep;43(9):394-402. doi: 10.1089/jir.2023.0014. Epub 2023 Jun 27. PMID: 37366802; PMCID: PMC10623078. | Baker FS, Wang J, Florez-Vargas O, Brand NR, Ogwang MD, Kerchan P, Reynolds SJ, Tenge CN, Were PA, Kuremu RT, Wekesa WN, Masalu N, Kawira E, Kinyera T, Otim I, Legason ID, Nabalende H, Chagaluka G, Mutalima N, Borgstein E, Liomba GN, Kamiza S, Mkandawire N, Mitambo C, Molyneux EM, Newton R, Prokunina-Olsson L, Mbulaiteye SM. | |||||||||||||||||||||||
22 | TB | P | ||||||||||||||||||||||||
23 | 3 Jan 2024 | Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control. | Wajja A, Nassanga B, Natukunda A, Serubanja J, Tumusiime J, Akurut H, Oduru G, Nassuuna J, Kabagenyi J, Morrison H, Scott H, Powell Doherty R, Marshall JL, Cabrera Puig I, Cose S, Kaleebu P, Webb EL, Satti I, McShane H, Elliott AM; TB042 Study Team. | P | ||||||||||||||||||||||
24 | 1 Apr 2023 | Thirty years of change in HIV incidence among adults in the Kyamulibwa General Population Cohort in rural southwest Uganda, 1989-2021. Int J Infect Dis. 2023 Apr;129:125-134. doi: 10.1016/j.ijid.2023.01.029. Epub 2023 Feb 2. PMID: 36736994. | Kasamba I, Mugisha J, Abaasa A, Makanga R, Ruzagira E, Kaleebu P, Seeley J, Newton R; Kyamulibwa General Population Cohort team of Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit. | VPDD | ||||||||||||||||||||||
25 | 19 Apr 2023 | Prevalence and Factors Associated with Illicit Drug and High-Risk Alcohol Use among Adolescents Living in Urban Slums of Kampala, Uganda | Hellen Kalungi 1, Onesmus Kamacooko 1, Jane Frances Lunkuse 1, Joy Namutebi 1, Rose Naluwooza 1, Matt A Price 2, Eugene Ruzagira 1, Yunia Mayanja 1 | P | ||||||||||||||||||||||
26 | Immunomodulation | |||||||||||||||||||||||||
27 | 19 Apr 2023 | Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens. Front Immunol. 2023 Apr 19;14:1148877. doi: 10.3389/fimmu.2023.1148877. eCollection 2023. PMID: 37153598 Free PMC article. | Nantambi H, Sembera J, Ankunda V, Ssali I, Kalyebi AW, Oluka GK, Kato L, Ubaldo B, Kibengo F, Katende JS, Gombe B, Baine C, Odoch G, Mugaba S, Sande OJ; COVID-19 Immunoprofiling Team; Kaleebu P, Serwanga J. | |||||||||||||||||||||||
28 | 19 Jun 2023 | Unravelling patient pathways in the context of antibacterial resistance in East Africa. | Keenan K, Fredricks KJ, Al Ahad MA, Neema S, Mwanga JR, Kesby M, Mushi MF, Aduda A, Green DL, Lynch AG, Huque SI, Mmbaga BT, Worthington H, Kansiime C, Olamijuwon E, Ntinginya NE, Loza O, Bazira J, Maldonado-Barragán A, Smith V, Decano AG, Njeru JM, Sandeman A, Stelling J, Elliott A, Aanensen D, Gillespie SH, Kibiki G, Sabiiti W, Sloan DJ, Asiimwe BB, Kiiru J, Mshana SE, Holden MTG; HATUA Consortium.BMC Infect Dis. 2023 Jun 19;23(1):414. doi: 10.1186/s12879-023-08392-9. PMID: 37337134 Free PMC article. | P | ||||||||||||||||||||||
29 | 14 Jan 2024 | HIVseqDB: a portable resource for NGS and sample metadata integration for HIV-1 drug resistance analysis. | Ssekagiri A, Jjingo D, Bbosa N, Bugembe DL, Kateete DP, Jordan IK, Kaleebu P, Ssemwanga D. | |||||||||||||||||||||||
30 | 13 Mar 2024 | HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection: A Multicenter Sub-Saharan African Study. | Lindquist L, Kilembe W, Karita E, Price MA, Kamali A, Kaleebu P, Tang J, Allen S, Hunter E, Gilmour J, Rowland-Jones SL, Sanders EJ, Hassan AS, Esbjörnsson J. | |||||||||||||||||||||||
31 | 3 May 2024 | Severe morbidity and hospital-based mortality from Rift Valley fever disease between November 2017 and March 2020 among humans in Uganda. Virology Journal. 2024 May 3;21(1):104. | Anywaine Z, Hansen C, Warimwe GM, Abu-Baker Mustapher G, Nyakarahuka L, Balinandi S, Ario AR, Lutwama JJ, Elliott A, Kaleebu P. | |||||||||||||||||||||||
32 | Vaccines for Viruses | |||||||||||||||||||||||||
33 | 1 Apr 2023 | Acceptability and applicability of biometric iris scanning for the identification and follow up of highly mobile research participants living in fishing communities along the shores of Lake Victoria in Kenya, Tanzania, and Uganda. | Okello E, Ayieko P, Kwena Z, Nanyonjo G, Bahemuka U, Price M, Bukusi E, Hashim R, Nakamanya S, Okech B, Kuteesa M, Oketch B, Ssetaala A, Ruzagira E, Kidega W, Fast P, Kibengo F, Grosskurth H, Seeley J, Kapiga S. Int J Med Inform. 2023 Apr;172:105018. doi: 10.1016/j.ijmedinf.2023.105018. Epub 2023 Feb 10. PMID: 36774907 | |||||||||||||||||||||||
34 | 3 Apr 2023 | UCP-LF and other assay methods for schistosome circulating anodic antigen between 1978 and 2022. | Fasogbon IV, Aja PM, Ondari EN, Adebayo I, Ibitoye OA, Egesa M, Tusubira D, Sasikumar S, Onohuean H. Biol Methods Protoc. 2023 Apr 3;8(1):bpad006. doi: 10.1093/biomethods/bpad006. eCollection 2023. PMID: 37197579 Free PMC article. Review. | |||||||||||||||||||||||
35 | 19 Apr 2023 | Prevalence and Factors Associated with Illicit Drug and High-Risk Alcohol Use among Adolescents Living in Urban Slums of Kampala, Uganda | Hellen Kalungi 1, Onesmus Kamacooko 1, Jane Frances Lunkuse 1, Joy Namutebi 1, Rose Naluwooza 1, Matt A Price 2, Eugene Ruzagira 1, Yunia Mayanja 1 | |||||||||||||||||||||||
36 | 1 May 2023 | Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory. | McLean C, Barry H, Kieh M, Anywaine Z, Tapima Rogers B, Doumbia S, Sirima SB, Serry-Bangura A, Habib Beavogui A, Gaddah A, Katwere M, Hendriks J, Keshinro B, Eholie S, Kibuuka H, Kennedy SB, Anzala O, Samai M, D'Ortenzio E, Leigh B, Sow S, Thiébaut R, Greenwood B, Watson-Jones D, Douoguih M, Luhn K, Robinson C. EBioMedicine. 2023 May;91:104562. doi: 10.1016/j.ebiom.2023.104562. Epub 2023 Apr 24. PMID: 37099841 Free PMC article. Clinical Trial. | |||||||||||||||||||||||
37 | 2 May 2023 | Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy. | Serwanga J, Baine C, Mugaba S, Ankunda V, Auma BO, Oluka GK, Kato L, Kitabye I, Sembera J, Odoch G, Ejou P, Nalumansi A, Gombe B, Musenero M, Kaleebu P. Front Immunol. 2023 May 2;14:1183983. doi: 10.3389/fimmu.2023.1183983. eCollection 2023. PMID: 37205095 Free PMC article. | |||||||||||||||||||||||
38 | 7 May 2023 | Effect of the "universal test and treat" policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda | Levicatus Mugenyi 1, Christian H Hansen 1 2, Philippe Mayaud 1 2, Janet Seeley 1 2, Robert Newton 1, Mastula Nanfuka 3, Andrew Abaasa 1, Kenneth Mugisha 3, Michael Etukoit 3, Pontiano Kaleebu 1 2, Eugene Ruzagira 1 2 | |||||||||||||||||||||||
39 | 9 May 2023 | Vaccination against SARS-CoV-2 in a rural Ugandan population | Joseph Mugisha 1, Bernard Mpairwe 1, Beatrice Kimono 1, Pontiano Kaleebu 1, Robert Newton 1 | |||||||||||||||||||||||
40 | 26 May 2023 | Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens | Hellen Nantambi 1 2 3, Jackson Sembera 1 2, Violet Ankunda 2, Ivan Ssali 1, Arthur Watelo Kalyebi 2 3, Gerald Kevin Oluka 1 2, Laban Kato 1, Bahemuka Ubaldo 1, Freddie Kibengo 1, Joseph Ssebwana Katende 1 2, Ben Gombe 1, Claire Baine 2, Geoffrey Odoch 1, Susan Mugaba 1, Obondo James Sande 3; COVID-19 Immunoprofiling Team; Pontiano Kaleebu 1 2, Jennifer Serwanga 1 2 | |||||||||||||||||||||||
41 | 1 Jun 2023 | Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal study. | Lawal BJ, Gallagher KE, Kitonsa J, Tindanbil D, Kasonia K, Drammeh A, Lowe B, Mukadi-Bamuleka D, Patterson C, Greenwood B, Samai M, Leigh B, Tetteh KKA, Ruzagira E, Watson-Jones D, Kavunga-Membo H. Int J Infect Dis. ;131:183-192. doi: 10.1016/j.ijid.2023.03.049. Epub 2023 Mar 30. PMID: 37001799 Free PMC article. | |||||||||||||||||||||||
42 | 2 Jun 2023 | The impact of the COVID-19 pandemic on the provision & utilisation of primary health care services in Goma, Democratic Republic of the Congo, Kambia district, Sierra Leone & Masaka district, Uganda. | Kasonia K, Tindanbil D, Kitonsa J, Baisley K, Zalwango F, Enria L, Mansaray A, James M, Nije Y, Tata DT, Lawal BJ, Drammeh A, Lowe B, Mukadi-Bamuleka D, Mounier-Jack S, Nakiyimba F, Obady P, Muhavi J, Bangura JS, Greenwood B, Samai M, Leigh B, Watson-Jones D, Kavunga-Membo H, Ruzagira E, Gallagher KE. PLoS One. 2023 Jun 2;18(6):e0286295. doi: 10.1371/journal.pone.0286295. eCollection 2023. PMID: 37267240 Free PMC article. | |||||||||||||||||||||||
43 | 9 Jun 2023 | Effect of the "universal test and treat" policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda. | Mugenyi L, Hansen CH, Mayaud P, Seeley J, Newton R, Nanfuka M, Abaasa A, Mugisha K, Etukoit M, Kaleebu P, Ruzagira E. Front Public Health. 2023 Jun 9;11:1187274. doi: 10.3389/fpubh.2023.1187274. eCollection 2023. PMID: 37361157 Free PMC article. | |||||||||||||||||||||||
44 | 10 Jun 2023 | HIV specific Th1 responses are altered in Ugandans with HIV and Schistosoma mansoni coinfection | Andrew Ekii Obuku 1, Jacqueline Kyosiimire Lugemwa 2, Andrew Abaasa 2, Moses Joloba 3, Song Ding 4, Justin Pollara 5, Guido Ferrari 5, Alexandre Harari 6, Giuseppe Pantaleo 7, Pontiano Kaleebu 2 8 | |||||||||||||||||||||||
45 | 14 Jun 2023 | Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial | Carolina Herrera 1, Jennifer Serwanga 2, Laura Else 3, Lebina Limakatso 4, Daniel Opoka 2, Andrew S Ssemata 5, Azure-Dee Pillay 6, Patricia Namubiru 2, Thabiso B Seiphetlo 6, Geoffrey Odoch 2, Susan Mugaba 2, Portia Seatlholo 4, Amara Alieu 3, Sujan Dilly Penchala 3, Richard Muhumuza 2, Berenice Alinde 7, Stefan Petkov 8, Kyle O'Hagan 7, Christian Callebaut 9, Janet Seeley 10, Helen Weiss 11, Saye Khoo 3, Francesca Chiodi 8, Clive M Gray 12, Pontiano Kaleebu 2, Emily L Webb 11, Neil Martinson 13, Julie Fox 14; CHAPS | |||||||||||||||||||||||
46 | 29 Jun 2023 | Targeting hepatitis B vaccine escape using immunogenetics in Bangladeshi infants. PMID: 37425840 Free PMC article. | Butler-Laporte G, Auckland K, Noor Z, Kabir M, Alam M, Carstensen T, Wojcik GL, Chong AY, Pomilla C, Noble JA, McDevitt SL, Smits G, Wareing S, van der Klis FR, Jeffery K, Kirkpatrick BD, Sirima S, Madhi S, Elliott A, Richards JB, Hill AV, Duggal P; PROVIDE authors, Cryptosporidiosis Birth Cohort authors; Sandhu MS, Haque R, Petri WA Jr, Mentzer AJ. medRxiv. 2023 Jun 29:2023.06.26.23291885. doi: 10.1101/2023.06.26.23291885. Preprint. | |||||||||||||||||||||||
47 | NCD Genomics | |||||||||||||||||||||||||
48 | 9 Apr 2023 | The causal effects of lipid traits on kidney function in Africans: bidirectional and multivariable Mendelian-randomization study | Christopher Kintu 1, Opeyemi Soremekun 2, Abram B Kamiza 3, Allan Kalungi 2, Richard Mayanja 2, Robert Kalyesubula 4, Bernard Bagaya S 5, Daudi Jjingo 6, June Fabian 7, Dipender Gill 8, Moffat Nyirenda 9, Dorothea Nitsch 10, Tinashe Chikowore 11, Segun Fatumo 12 | |||||||||||||||||||||||
49 | 9 May 2023 | Multi-trait discovery and fine-mapping of lipid loci in 125,000 individuals of African ancestry | Abram Bunya Kamiza # 1 2 3, Sounkou M Touré # 1 4, Feng Zhou # 5, Opeyemi Soremekun 1, Cheickna Cissé 4 6, Mamadou Wélé 2 6, Aboubacrine M Touré 6, Oyekanmi Nashiru 7, Manuel Corpas 8, Moffat Nyirenda 9, Amelia Crampin 2, Jeffrey Shaffer 10, Seydou Doumbia 4 11, Eleftheria Zeggini 12 13, Andrew P Morris 14, Jennifer L Asimit 5, Tinashe Chikowore 3 15 16 17, Segun Fatumo 18 19 20 21 | |||||||||||||||||||||||
50 | Mental Health | |||||||||||||||||||||||||
51 | M | |||||||||||||||||||||||||
52 | Violence | |||||||||||||||||||||||||
53 | 7 Jan 2023 | Prevalence, Perpetrators, and Factors Associated With Intimate Partner Violence Among Adolescents Living in Urban Slums of Kampala, Uganda | Yunia Mayanja 1 2, Onesmus Kamacooko 1, Jane Frances Lunkuse 1, Nambusi Kyegombe 1 2, Eugene Ruzagira 1 2 | V | ||||||||||||||||||||||
54 | 19 May 2023 | Evaluating use of mass-media communication intervention 'MTV-Shuga' on increased awareness and demand for HIV and sexual health services by adolescent girls and young women in South Africa: an observational study | Natsayi Chimbindi 1 2, Nondumiso Mthiyane 1, Glory Chidumwa 1 3, Thembelihle Zuma 1 2, Jaco Dreyer 1, Isolde Birdthistle 4, Sian Floyd 5, Nambusi Kyegombe 6, Chris Grundy 4, Cherie Cawood 7, Siva Danaviah 1, Theresa Smit 1, Deenan Pillay 8, Kathy Baisley 1 9, Guy Harling 1 2, Janet Seeley 1 10, Maryam Shahmanesh 11 2 | V | ||||||||||||||||||||||
55 | Cardiometabolic | |||||||||||||||||||||||||
56 | 19 Apr 2023 | Asthma inflammatory phenotypes on four continents: most asthma is non-eosinophilic | Lucy Pembrey 1, Collin Brooks 2, Harriet Mpairwe 3, Camila A Figueiredo 4, Aida Y Oviedo 5, Martha Chico 5, Hajar Ali 2, Irene Nambuya 3, Pius Tumwesige 3, Steven Robertson 1, Charlotte E Rutter 1, Karin van Veldhoven 6, Susan Ring 7 8, Mauricio L Barreto 4 9, Philip J Cooper 5 10 11, John Henderson 7, Alvaro A Cruz 12 13, Jeroen Douwes 2, Neil Pearce 1 2; WASP Study Group | |||||||||||||||||||||||
57 | Disability | |||||||||||||||||||||||||
58 | ||||||||||||||||||||||||||
59 | ||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||
61 | ||||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||
63 | ||||||||||||||||||||||||||
64 | ||||||||||||||||||||||||||
65 | ||||||||||||||||||||||||||
66 | ||||||||||||||||||||||||||
67 | ||||||||||||||||||||||||||
68 | ||||||||||||||||||||||||||
69 | ||||||||||||||||||||||||||
70 | ||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||
100 | ||||||||||||||||||||||||||